Short-course Radiotherapy Followed by Sequential Chemotherapy With or Without PD-1 Monoclonal Antibody and Bevacizumab as Total Neoadjuvant Therapy in pMMR/MSS Locally Advanced Rectal Cancer （SPARK）

Conditions

• pMMR/MSS Locally Advanced Rectal Cancer

Interventions

• OTHER: Short-course radiotherapy followed by sequential chemotherapy combined with PD-1 monoclonal antibody and bevacizumab
• OTHER: Short-course radiotherapy followed by sequential chemotherapy

Sponsor

Dechang Diao